Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology
|
January 24, 1998
Transition of serum vitellogenin cycle in Sakhalin taimen (Hucho perryi)
N Hiramatsu, M Shimizu, H Fukada, et al.
British Journal of Pharmacology
|
April 17, 2007
Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis
J Yao, Y Zhu, W Sun, et al.
Nihon Kango Kagakkai Shi = Journal of Japan Academy of Nursing Science
|
February 1, 1997
[The effect on bowel sounds of very hot compresses applied to the lumbar region]
M Hishinuma, N Hiramatsu, M Kasuga, et al.
Rheumatology (Oxford, England)
|
April 9, 2008
Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions
N Hiramatsu, T Kuroiwa, H Ikeuchi, et al.
Rheumatology (Oxford, England)
|
April 10, 2008
Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation
N Sakurai, T Kuroiwa, H Ikeuchi, et al.
Alimentary Pharmacology & Therapeutics
|
November 13, 2015
Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
K Ashida, Y Sakurai, T Hori, et al.
Alimentary Pharmacology & Therapeutics
|
July 24, 2015
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
K Ashida, Y Sakurai, A Nishimura, et al.
Journal of Viral Hepatitis
|
September 6, 2000
Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group
A Kasahara, N Hayashi, K Mochizuki, et al.
Hepatology (Baltimore, Md.)
|
June 1, 1994
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
N Hiramatsu, N Hayashi, K Katayama, et al.
Anesthesiology
|
January 19, 2000
Sevoflurane does not inhibit human platelet aggregation induced by thrombin
S Nozuchi, T Mizobe, H Aoki, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology
|
January 24, 1998
Transition of serum vitellogenin cycle in Sakhalin taimen (Hucho perryi)
N Hiramatsu, M Shimizu, H Fukada, et al.
British Journal of Pharmacology
|
April 17, 2007
Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis
J Yao, Y Zhu, W Sun, et al.
Nihon Kango Kagakkai Shi = Journal of Japan Academy of Nursing Science
|
February 1, 1997
[The effect on bowel sounds of very hot compresses applied to the lumbar region]
M Hishinuma, N Hiramatsu, M Kasuga, et al.
Rheumatology (Oxford, England)
|
April 9, 2008
Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions
N Hiramatsu, T Kuroiwa, H Ikeuchi, et al.
Rheumatology (Oxford, England)
|
April 10, 2008
Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation
N Sakurai, T Kuroiwa, H Ikeuchi, et al.
Alimentary Pharmacology & Therapeutics
|
November 13, 2015
Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
K Ashida, Y Sakurai, T Hori, et al.
Alimentary Pharmacology & Therapeutics
|
July 24, 2015
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
K Ashida, Y Sakurai, A Nishimura, et al.
Journal of Viral Hepatitis
|
September 6, 2000
Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group
A Kasahara, N Hayashi, K Mochizuki, et al.
Hepatology (Baltimore, Md.)
|
June 1, 1994
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
N Hiramatsu, N Hayashi, K Katayama, et al.
Anesthesiology
|
January 19, 2000
Sevoflurane does not inhibit human platelet aggregation induced by thrombin
S Nozuchi, T Mizobe, H Aoki, et al.
Page
of 7